Dechert advised Pharnext SA, a French biopharmaceutical company pioneering a new approach to the discovery of innovative drugs based on the combination of existing drugs, in…
Pharnext’s Strategic Partnership with Tasly Pharmaceutical
Dechert advised Pharnext SA, a French biopharmaceutical company pioneering a new approach to the discovery of innovative drugs based on the combination of existing drugs, in…